Del Carmen Jeffrey's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Aug 22, 2022
- Accession no.
- 0001161697-22-000405
- Filed
- Aug 22, 2022
- Trade date
- Aug 19, 2022
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $198.7K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Del Carmen JeffreyCIK 0001816477 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares were sold in various lots from $14.00 to $14.23 per share. The listed sales price represents a weighted average price for the shares sold.
Referenced by the price of 1 transaction in Table I.
- F2
Shares were sold for personal reasons, and does not relate to any disagreements with the Company. Mr. Del Carmen remains an officer of the Company.
Referenced by the price of 1 transaction in Table I.